ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Transactions Affecting Stockholders' Equity (Details Narrative)

Transactions Affecting Stockholders' Equity (Details Narrative) - USD ($)						3 Months Ended	6 Months Ended	9 Months Ended
	Aug. 26, 2017	Aug. 25, 2017	Aug. 21, 2017	Jun. 12, 2017	Jul. 30, 2015	Sep. 30, 2017	Jun. 30, 2017	Sep. 30, 2017	Sep. 30, 2016	Aug. 15, 2017	Dec. 31, 2016	May 24, 2016	Dec. 11, 2015	May 05, 2010
Common stock, shares authorized						50,000,000		50,000,000			50,000,000
Preferred stock, shares authorized						1,000,000		1,000,000			1,000,000
Preferred stock, par value						$ 0.0005		$ 0.0005			$ 0.0005
Common stock right's exercise price													$ 1.35
Equity method investment ownership percentage						50.00%		50.00%
Stock option granted							600,000	25,000
Stock option, expected life							4 years 9 months	4 years 6 months
Weighted average risk rate							1.81%	1.62%
Stock option, dividend yield							0.00%	0.00%
Stock option, expected volatility							44.51%	38.59%
Stock option, exercised						592,000		682,000
Proceeds from stock option exercised						$ 752,000		$ 854,000
Common stock, shares issued						27,046,593		27,046,593			26,313,593
Tender Offer [Member]
Common stock, shares issued			16,200,000
Number of common stock shares purchased		4,323,335
Common stock share price	$ 2.30
Common stock purchased percentage		73.00%
Shares proposed to purchased in tender offer percentage			24.70%
Common stock shares outstanding			16,200,000
Trading price per share										$ 2.13
Offer expire date		Sep. 25, 2017
Purchase price per share		$ 2.30
Purchase price amount		$ 9,900,000
Tender Offer [Member] \| Maximum [Member]
Number of common stock shares purchased	4,000,000
Ted Karkus [Member]
Number of common stock shares sold		364,954
Robert V. Cuddihy, Jr. [Member]
Number of common stock shares sold		358,621
American Stock Transfer & Trust Company [Member]
Number of common stock shares purchased		5,910,327
American Stock Transfer & Trust Company [Member] \| Minimum [Member]
Number of common stock shares purchased		9,338
BML Investment Partners, L.P [Member]
Equity method investment ownership percentage		13.60%
Investments owned shares		2,322,627
Number of common stock shares sold		1,695,305
2015 Equity Line of Credit [Member] \| Dutchess [Member]
Stock issued during period shares					3,200,000
Maximum number of shares of draw down notice					500,000
Derivative transaction, conditions description								The purchase price shall be set at ninety-five percent (95%) of the volume weighted average price (VWAP) of the Common Stock during the one trading day immediately following our put notice. We have the right to withdraw all or any portion of any put, except that portion of the put that has already been sold to a third party, including any portion of a put that is below the minimum acceptable price set forth on the put notice, before the closing. In the event Dutchess receives more than a five percent (5%) return on the net sales for a specific put, Dutchess must remit such excess proceeds to us; however, in the event Dutchess receives less than a five percent (5%) return on the net sales for a specific put, Dutchess will have the right to deduct from the proceeds of the put amount on the applicable closing date so Dutchesss return will equal five percent (5%).
Number of shares beneficially held maximum percentage								4.99%
Available for sale, shares						$ 2,450,000		$ 2,450,000
Stock Purchase Agreement [Member]
Equity method investment ownership percentage				6.20%
Options outstanding - shares				17,200,000
Common stock, shares purchased				1,061,980
Stock Purchase Agreement [Member] \| Leventhal Holders [Member]
Consideration paid				$ 1,858,465
Share price				$ 1.75
Chairman and Chief Executive Officer [Member] \| Rights Agreement [Member]
Equity method investment ownership percentage required for rights exercisable under right agreement								20.00%
Stockholder Rights Plan [Member]
Common stock right's exercise price						$ 45		$ 45
Equity method investment ownership percentage required for rights exercisable under right agreement								15.00%
Percentage of discount on exercise of right								50.00%
Rights agreement expiration date								Jun. 18, 2024
2010 Equity Compensation Plan [Member]
Plan provides total number of shares of common stock issued												700,000		3,200,000
2010 Equity Compensation Plan [Member] \| Employees [Member]
Stock option granted								625,000
Stock option shares exercisable						25,000		25,000
Common stock option exercisable, per share								$ 2.15
Stock option vesting period								3 years
2010 Equity Compensation Plan [Member] \| Employees 1 [Member]
Stock option shares exercisable						600,000		600,000
Common stock option exercisable, per share								$ 2.00
Stock option vesting period								4 years
1997 Equity Compensation Plan [Member]
Plan provides total number of shares of common stock issued														900,000
2010 Plan [Member]
Options outstanding - shares						1,642,000		1,642,000
Available for grant, shares						108,659		108,659
2010 Directors' Equity Compensation Plan [Member]
Number of shares issued during period								425,000
Common stock, shares issued						147,808		147,808